Evaluation of an in-house pan- Malassezia quantitative PCR in human clinical samples
Medical Mycology · 2024
DOI: 10.1093/mmy/myae095 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Medical Mycology, 2024. Verfasst von Victor Euzen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mycology and Parasitology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, 1 av. Claude Vellefaux, 75010 Paris, France. Hauptthemen laut MEDLINE: Malassezia, Real-Time Polymerase Chain Reaction, RNA, Ribosomal, 28S, Skin. Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
Althought Malassezia spp. have been involved in various pathologies, they are an integral part of the cutaneous, gut, oral, ears, nose and throat (ENT) mycobiota. Since Malassezia are difficult to grow in culture, unexhaustive molecular biology methods have been developed to detect them. The aim of the study was to evaluate an in-house pan-Malassezia quantitative polymerase chain reaction (panM-qPCR) on various clinical human samples and determine Malassezia burden in various human mycobiota. The panM-qPCR was designed to target the repeated 28S rDNA gene from all Malassezia species. We used the assay to quantify the Malassezia burden on 361 samples from 161 subjects (80 skin swabs from 10 healthy volunteers (HV), 13 samples from 2 seborrheic dermatitis patients (SD), 90 skin samples from 19 burned patients, 119 stool samples from 89 immunocompromised patients, 59 ENT samples from 41 patients). For HV, the amount of Malassezia was different according to the swabbed areas. Quantification cycle (Cq) in SD is lower than in HV. In burned patients, Cq was significantly lower compared to HV. In stool samples, 6.7% were positive for Malassezia spp. with a high Cq. For the ENT area, a higher proportion of positive specimens were detected in ear samples than in nose samples. Our findings emphasized the importance of qPCR, confirming elevated Malassezia spp. levels on individuals' faces and scalps, increased burden in SD patients and in severely burnt patients than in HV. The pan-MqPCR appears to be a promising tool for studying Malassezia in various human mycobiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mycology and Parasitology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, 1 av. Claude Vellefaux, 75010 Paris, France.
- Natl. Ref. Center for Invasive Mycoses and Antifungals, Institut Pasteur, 25 Rue du Dr Roux, 75015 Paris, France.
ORCID-Profile: Victor Euzen, Théo Ghelfenstein-Ferreira, Sarah Dellière, Marie Desnos-Ollivier, Alexandre Alanio
Zitieren
APA
Euzen, V., Ghelfenstein-Ferreira, T., Benhadid-Brahmi, Y., Teboul, A., Dellière, S., Benderdouche, M., Charlier, V., Desnos-Ollivier, M., Hamane, S., & Alanio, A. (2024). Evaluation of an in-house pan- Malassezia quantitative PCR in human clinical samples. Medical Mycology. https://doi.org/10.1093/mmy/myae095
Vancouver
Euzen V, Ghelfenstein-Ferreira T, Benhadid-Brahmi Y, Teboul A, Dellière S, Benderdouche M, et al. Evaluation of an in-house pan- Malassezia quantitative PCR in human clinical samples. Medical Mycology. 2024. doi:10.1093/mmy/myae095
BibTeX
@article{Euzen2024,
author = {Euzen, Victor and Ghelfenstein-Ferreira, Théo and Benhadid-Brahmi, Yasmine and Teboul, Alexandra and Dellière, Sarah and Benderdouche, Mazouz and Charlier, Véronique and Desnos-Ollivier, Marie and Hamane, Samia and Alanio, Alexandre},
title = {Evaluation of an in-house pan- Malassezia quantitative PCR in human clinical samples},
journal = {Medical Mycology},
year = {2024},
doi = {10.1093/mmy/myae095}
}
EUVIMED